These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2349880)

  • 1. Rapidly progressive type III Gaucher disease: deterioration following partial splenectomy.
    Kyllerman M; Conradi N; Månsson JE; Percy AK; Svennerholm L
    Acta Paediatr Scand; 1990 Apr; 79(4):448-53. PubMed ID: 2349880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaucher disease: fate of the splenic remnant after partial splenectomy--a case of rapid enlargement.
    Fleshner PR; Astion DJ; Ludman MD; Aufses AH; Grabowski GA; Dolgin SE
    J Pediatr Surg; 1989 Jun; 24(6):610-2. PubMed ID: 2738830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.
    Erikson A
    Acta Paediatr Scand Suppl; 1986; 326():1-42. PubMed ID: 3296644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norrbottnian type of Gaucher disease--clinical, biochemical and molecular biology aspects: successful treatment with bone marrow transplantation.
    Svennerholm L; Erikson A; Groth CG; Ringdén O; Månsson JE
    Dev Neurosci; 1991; 13(4-5):345-51. PubMed ID: 1817041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal hemorrhage caused by disease progression after partial splenectomy for type III Gaucher's disease.
    Holcomb GW; Greene HL
    J Pediatr Surg; 1993 Dec; 28(12):1572-4. PubMed ID: 8301495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme infusion therapy of the Norrbottnian (type 3) Gaucher disease.
    Erikson A; Aström M; Månsson JE
    Neuropediatrics; 1995 Aug; 26(4):203-7. PubMed ID: 8544959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical outcome of marrow transplantation for Gaucher disease of the Norrbottnian type.
    Erikson A; Groth CG; Månsson JE; Percy A; Ringdén O; Svennerholm L
    Acta Paediatr Scand; 1990; 79(6-7):680-5. PubMed ID: 2386062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogenic bone marrow transplantation in severe Gaucher disease.
    Tsai P; Lipton JM; Sahdev I; Najfeld V; Rankin LR; Slyper AH; Ludman M; Grabowski GA
    Pediatr Res; 1992 May; 31(5):503-7. PubMed ID: 1603628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten years' experience of bone marrow transplantation for Gaucher disease.
    Ringdén O; Groth CG; Erikson A; Granqvist S; Månsson JE; Sparrelid E
    Transplantation; 1995 Mar; 59(6):864-70. PubMed ID: 7701581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease.
    Conradi NG; Kalimo H; Sourander P
    Acta Neuropathol; 1988; 75(4):385-90. PubMed ID: 3364161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial splenectomy in Gaucher's disease.
    Rubin M; Yampolski I; Lambrozo R; Zaizov R; Dintsman M
    J Pediatr Surg; 1986 Feb; 21(2):125-8. PubMed ID: 3950849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of partial splenectomy for type I Gaucher disease.
    Zimran A; Elstein D; Schiffmann R; Abrahamov A; Goldberg M; Bar-Maor JA; Brady RO; Guzzetta PC; Barton NW
    J Pediatr; 1995 Apr; 126(4):596-7. PubMed ID: 7699540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapidly developing bone destruction in a patient with type 1 Gaucher disease].
    Boda A; Erdós M; Tóth J; Nagy J; Maródi L
    Orv Hetil; 2003 Mar; 144(13):625-7. PubMed ID: 12728788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies.
    Conradi NG; Sourander P; Nilsson O; Svennerholm L; Erikson A
    Acta Neuropathol; 1984; 65(2):99-109. PubMed ID: 6524300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial splenectomy for massive splenomegaly secondary to Gaucher's disease.
    Thomas WE; Winfield DA
    Postgrad Med J; 1991 Dec; 67(794):1072-4. PubMed ID: 1800968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy in Gaucher Disease: A Call for Minimally Invasive Surgery.
    Freund MR; Reissman P; Zimran A; Alberton J
    Surg Laparosc Endosc Percutan Tech; 2018 Apr; 28(2):86-89. PubMed ID: 29521675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher disease--Norrbottnian type. I. General clinical description.
    Dreborg S; Erikson A; Hagberg B
    Eur J Pediatr; 1980 Mar; 133(2):107-18. PubMed ID: 7363908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated skeletal deterioration after splenectomy in Gaucher type 1 disease.
    Rose JS; Grabowski GA; Barnett SH; Desnick RJ
    AJR Am J Roentgenol; 1982 Dec; 139(6):1202-4. PubMed ID: 6983268
    [No Abstract]   [Full Text] [Related]  

  • 19. Gaucher disease (type III): intellectual profile.
    Erikson A; Karlberg J; Skogman AL; Dreborg S
    Pediatr Neurol; 1987; 3(2):87-91. PubMed ID: 3508057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher disease: treatment of hypersplenism with splenic embolization.
    Thanopoulos BD; Frimas CA; Mantagos SP; Beratis NG
    Acta Paediatr Scand; 1987 Nov; 76(6):1003-7. PubMed ID: 3425305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.